New EORTC compounds.
Lelieveld
P
P
Radiobiological Institute TNO, Rijswijk, The Netherlands.
Hendriks
H R
HR
D000477:Alkylating Agents / Q000494:pharmacology; D000818:Animals; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000494:pharmacology*; D001388:Aziridines; D004354:Drug Screening Assays, Antitumor; D004791:Enzyme Inhibitors / Q000494:pharmacology; D005060:Europe; D006801:Humans; D045563:Indolequinones; D007211:Indoles / Q000009:adverse effects / Q000737:chemistry / Q000494:pharmacology; D007783:Lactones / Q000737:chemistry / Q000494:pharmacology; D018942:Macrolides; D051379:Mice; D009607:Nitrosourea Compounds / Q000494:pharmacology; D009938:Organizations; D011809:Quinones / Q000009:adverse effects / Q000737:chemistry / Q000494:pharmacology
D000477:Alkylating Agents; D000970:Antineoplastic Agents; D001388:Aziridines; D004791:Enzyme Inhibitors; D045563:Indolequinones; D007211:Indoles; D007783:Lactones; D018942:Macrolides; D009607:Nitrosourea Compounds; D011809:Quinones; C041443:rhizoxin; C060817:apaziquone